BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 27380775)

  • 1. Global identification of hnRNP A1 binding sites for SSO-based splicing modulation.
    Bruun GH; Doktor TK; Borch-Jensen J; Masuda A; Krainer AR; Ohno K; Andresen BS
    BMC Biol; 2016 Jul; 14():54. PubMed ID: 27380775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blocking of an intronic splicing silencer completely rescues IKBKAP exon 20 splicing in familial dysautonomia patient cells.
    Bruun GH; Bang JMV; Christensen LL; Brøner S; Petersen USS; Guerra B; Grønning AGB; Doktor TK; Andresen BS
    Nucleic Acids Res; 2018 Sep; 46(15):7938-7952. PubMed ID: 29762696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hnRNP A1 controls HIV-1 mRNA splicing through cooperative binding to intron and exon splicing silencers in the context of a conserved secondary structure.
    Damgaard CK; Tange TO; Kjems J
    RNA; 2002 Nov; 8(11):1401-15. PubMed ID: 12458794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An intron element modulating 5' splice site selection in the hnRNP A1 pre-mRNA interacts with hnRNP A1.
    Chabot B; Blanchette M; Lapierre I; La Branche H
    Mol Cell Biol; 1997 Apr; 17(4):1776-86. PubMed ID: 9121425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalent deep intronic c. 639+919 G>A GLA mutation causes pseudoexon activation and Fabry disease by abolishing the binding of hnRNPA1 and hnRNP A2/B1 to a splicing silencer.
    Palhais B; Dembic M; Sabaratnam R; Nielsen KS; Doktor TK; Bruun GH; Andresen BS
    Mol Genet Metab; 2016 Nov; 119(3):258-269. PubMed ID: 27595546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hnRNP A1 contacts exon 5 to promote exon 6 inclusion of apoptotic Fas gene.
    Oh Hk; Lee E; Jang HN; Lee J; Moon H; Sheng Z; Jun Y; Loh TJ; Cho S; Zhou J; Green MR; Zheng X; Shen H
    Apoptosis; 2013 Jul; 18(7):825-35. PubMed ID: 23430061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic control of carcinoembryonic antigen-related cell adhesion molecule-1 (CEACAM1) splice isoforms by the heterogeneous nuclear ribonuclear proteins hnRNP L, hnRNP A1, and hnRNP M.
    Dery KJ; Gaur S; Gencheva M; Yen Y; Shively JE; Gaur RK
    J Biol Chem; 2011 May; 286(18):16039-51. PubMed ID: 21398516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splice-shifting oligonucleotide (SSO) mediated blocking of an exonic splicing enhancer (ESE) created by the prevalent c.903+469T>C MTRR mutation corrects splicing and restores enzyme activity in patient cells.
    Palhais B; Præstegaard VS; Sabaratnam R; Doktor TK; Lutz S; Burda P; Suormala T; Baumgartner M; Fowler B; Bruun GH; Andersen HS; Kožich V; Andresen BS
    Nucleic Acids Res; 2015 May; 43(9):4627-39. PubMed ID: 25878036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. hnRNP A1 and hnRNP F modulate the alternative splicing of exon 11 of the insulin receptor gene.
    Talukdar I; Sen S; Urbano R; Thompson J; Yates JR; Webster NJ
    PLoS One; 2011; 6(11):e27869. PubMed ID: 22132154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position-dependent effects of hnRNP A1/A2 in SMN1/2 exon7 splicing.
    Qiu J; Qu R; Lin M; Xu J; Zhu Q; Zhang Z; Sun J
    Biochim Biophys Acta Gene Regul Mech; 2022 Nov; 1865(8):194875. PubMed ID: 36208849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperative-binding and splicing-repressive properties of hnRNP A1.
    Okunola HL; Krainer AR
    Mol Cell Biol; 2009 Oct; 29(20):5620-31. PubMed ID: 19667073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exon identity established through differential antagonism between exonic splicing silencer-bound hnRNP A1 and enhancer-bound SR proteins.
    Zhu J; Mayeda A; Krainer AR
    Mol Cell; 2001 Dec; 8(6):1351-61. PubMed ID: 11779509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.
    Rooke N; Markovtsov V; Cagavi E; Black DL
    Mol Cell Biol; 2003 Mar; 23(6):1874-84. PubMed ID: 12612063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control of hnRNP A1 alternative splicing: an intron element represses use of the common 3' splice site.
    Simard MJ; Chabot B
    Mol Cell Biol; 2000 Oct; 20(19):7353-62. PubMed ID: 10982852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct sets of adjacent heterogeneous nuclear ribonucleoprotein (hnRNP) A1/A2 binding sites control 5' splice site selection in the hnRNP A1 mRNA precursor.
    Hutchison S; LeBel C; Blanchette M; Chabot B
    J Biol Chem; 2002 Aug; 277(33):29745-52. PubMed ID: 12060656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SMN2 exon 7 splicing is inhibited by binding of hnRNP A1 to a common ESS motif that spans the 3' splice site.
    Doktor TK; Schroeder LD; Vested A; Palmfeldt J; Andersen HS; Gregersen N; Andresen BS
    Hum Mutat; 2011 Feb; 32(2):220-30. PubMed ID: 21120954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. hnRNP L and hnRNP A1 induce extended U1 snRNA interactions with an exon to repress spliceosome assembly.
    Chiou NT; Shankarling G; Lynch KW
    Mol Cell; 2013 Mar; 49(5):972-82. PubMed ID: 23394998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. hnRNP A1 recruited to an exon in vivo can function as an exon splicing silencer.
    Del Gatto-Konczak F; Olive M; Gesnel MC; Breathnach R
    Mol Cell Biol; 1999 Jan; 19(1):251-60. PubMed ID: 9858549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.